Tr1X
PrivateLast Round
Grant
Jun 25, 2026
Total Funding Raised
$78M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Tr1X is a biotechnology company developing off-the-shelf allogeneic regulatory T cell therapies to treat autoimmune and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Tr1X Comps
Public and private peers based on sector, stage, and business model.
Tr1X Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 25, 2026 | ||||
| Series B | Oct 14, 2025 | ||||
| Grant | Apr 4, 2025 | ||||
| Grant | Jan 1, 2024 |
Key People
Founding team and executive leadership
Tr1X Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The Column Group | Series B, Grant |
| Neva SGR | Grant, Series B |
| The Chernin Group | Grant |
| California Institute for Regenerative Medicine | Grant |
| Alexandria Venture Investments | Grant, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 25, 2026
Received $8M grant from California Institute for Regenerative Medicine.
- Apr 27, 2026
New data on Engineered Tr1 Treg cell therapies to be presented at ASGCT 2026.
Tr1X Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Tr1X's valuation, stock price, and market status.